Evicenter
P&T meetings

Imsidolimab

Generalized pustular psoriasis

Regulatory submission
BLA submitted December 2025
Last updated
85 sources

Product information and disease descriptionProduct description

Product information

16 evidence topics · 14 sources

Average sales price and wholesale acquisition cost

Not applicable.

Contraindications/Warnings/Precautions/Adverse effects
Warnings and precautions

Not applicable.

Drug/Drug, drug/disease interactions
Effects of other drugs on Imsidolimab

No evidence found.

Effects of Imsidolimab on other drugs

No evidence found.

Access and distribution

No evidence found.

Effect of Imsidolimab on quality measures

No evidence found.